Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Large-scale testing (Phase 3)Active Not RecruitingNCT03155997
What this trial is testing

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 5,637
Testing effectiveness (Phase 2)Study completedNCT00217087
What this trial is testing

Endoscopic Therapy of Early Cancer in Barretts Esophagus

Who this might be right for
Early Stage Esophageal AdenocarcinomaBarrett Esophagus
Mayo Clinic 73
Not applicableEnded earlyNCT03267368
What this trial is testing

Comprehensive Care Program SBRT

Who this might be right for
Lung CancerSmokingCopd
Corewell Health East 1
Testing effectiveness (Phase 2)Looking for participantsNCT01766297
What this trial is testing

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmBreast Tumor+1 more
Proton Collaborative Group 132
Testing effectiveness (Phase 2)Looking for participantsNCT07407920
What this trial is testing

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 120
Early research (Phase 1)UnknownNCT05942508
What this trial is testing

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Who this might be right for
Limited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy
Jinming Yu 20
Large-scale testing (Phase 3)UnknownNCT00301925
What this trial is testing

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 4,400
Large-scale testing (Phase 3)Study completedNCT04271189
What this trial is testing

Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

Who this might be right for
Newly Diagnosed Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma 108
Large-scale testing (Phase 3)Study completedNCT02350738
What this trial is testing

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Who this might be right for
Mild Cognitive ImpairmentDementia, Mild
Ki Woong Kim 64
Testing effectiveness (Phase 2)Ended earlyNCT00447421
What this trial is testing

Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Who this might be right for
Small Cell Lung CancerCarcinoma, Small CellSCLC
Eli Lilly and Company 9
Not applicableStudy completedNCT00246116
What this trial is testing

Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Indiana University 15
Testing effectiveness (Phase 2)Study completedNCT05017493
What this trial is testing

Treatment of Covid-19 With a Herbal Compound, Xagrotin

Who this might be right for
Covid19
Biomad AS 661
Testing effectiveness (Phase 2)Ended earlyNCT04418648
What this trial is testing

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Who this might be right for
Small Cell Lung Cancer Limited Stage
Sun Yat-sen University 170
Not applicableUnknownNCT03840408
What this trial is testing

Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai 10th People's Hospital 1,753
Testing effectiveness (Phase 2)Looking for participantsNCT06321991
What this trial is testing

Nodular Shrinking in Dupuytren Disease

Who this might be right for
Dupuytren's Disease
Universitaire Ziekenhuizen KU Leuven 80
Testing effectiveness (Phase 2)Study completedNCT03345420
What this trial is testing

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage 0 Breast Cancer+6 more
University of Utah 102
Testing effectiveness (Phase 2)Study completedNCT00744549
What this trial is testing

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Who this might be right for
Cancer of the ProstateProstate CancerProstatic Neoplasms
University Health Network, Toronto 16
Not applicableUnknownNCT02368574
What this trial is testing

Comparison of Class II and Class III Hysterectomy in Early Stage Cervical Cancer Cervical Cancer

Who this might be right for
Cervical Cancer
Chinese Gynecological Oncology Group 500
Not applicableStudy completedNCT01553097
What this trial is testing

Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty

Who this might be right for
Breast CancerNeurocognitive ImpairmentQuality of Life
Virginia Commonwealth University 51
Next Page